Related Experiment Video
Updated: Jan 23, 2026
07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.4K
[Cognitive aging of bipolar patients]
Samuel Kohler1, Emeline Marlinge2
1Unité de psychiatrie de la personne âgée, Hôpitaux Pitié Salpêtrière - Charles Foix, Ivry-sur-Seine, France.
Summary
Aging bipolar disorder patients face cognitive decline, potentially linked to neurodevelopmental issues, neuroprogression, or other brain diseases. Understanding these factors is crucial for better patient outcomes.
Area of Science:
- Neuroscience
- Psychiatry
- Gerontology
Background:
- Bipolar disorder is a severe mood disorder with high morbidity and mortality.
- An emerging population of aging bipolar patients requires specific research.
- Cognitive impairment significantly impacts psychosocial outcomes in bipolar disorder.
Purpose of the Study:
- To explore the association between bipolar disorder and cognitive impairment in aging patients.
- To understand the heterogeneity of cognitive decline in the aging bipolar population.
- To review existing paradigms explaining cognitive changes in bipolar disorder.
Main Methods:
- Review of existing literature on bipolar disorder, cognitive aging, and neuroprogression.
- Analysis of three proposed paradigms: cognitive endophenotypes, neuroprogression, and comorbid neurological diseases.
- Consideration of factors influencing cognitive function in aging bipolar patients.
Main Results:
- Cognitive decline in aging bipolar patients may stem from distinct cognitive endophenotypes interacting with normal aging.
- The neuroprogression paradigm suggests cumulative brain changes from mood episodes contribute to cognitive decline.
- Bipolar patients may develop vascular dementia or other neurodegenerative diseases, alongside other influencing factors.
Conclusions:
- Multiple factors contribute to cognitive heterogeneity in aging bipolar disorder patients.
- Understanding cognitive endophenotypes, neuroprogression, and comorbid conditions is key.
- Further research is needed to elucidate neuropathological mechanisms and improve patient care.
More Related Videos
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
192
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
192
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
246
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
246
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
235
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
235
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
202
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
202
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
245
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
245
01:30Bipolar Disorder
663
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
663